News for Entheon Biomedical Corp. (ENBI.CN)

SkyQuest's Psychedelic Drugs Market report provides actionable insights for individuals interested in valuable data, trends, and opportunities in a rapidly...

CONDENSED INTERIM CONSOLIDATED FINANCIAL STATEMENTS FOR THE THREE AND SIX MONTHS ENDED SEPTEMBER 30, 2022 ... | November 15, 2022

/PRNewswire/ -- FinancialNewsMedia.com News Commentary - Anti-anxiety drugs are medications that are used to treat anxiety disorders that are mainly used to...

/PRNewswire/ -- Toronto's Center for Addiction and Mental Health (CAMH) just received the first-ever federal grant to study whether the active component of...

TORONTO, August 08, 2022--Cybin Inc. (NEO:CYBN) (NYSE American:CYBN) ("Cybin" or the "Company"), a biopharmaceutical company focused on progressing "Psychedelics to TherapeuticsTM", today reported unaudited financial results for its first quarter ended June 30, 2022 and recent business highlights.

– Company reiterates key pipeline and strategic milestones for 2022 –

Want to get the latest psychedelics industry news in your inbox every week? Subscribe to our Newsletter to become a Psychedelics Insider.

Share this article MIAMI – Ehave, Inc. (OTC Pink: EHVVF), a leading healthcare services and technology company, announced today its KetaDASH subsidiary will ...

This post contains sponsored advertising content. This content is for informational purposes only and is not intended to be investing advice.

Entheon Biomedical Corp. ENTBF announced a non-brokered private placement financing for up to 30,000,000 Units at a price of CDN$0.10 per unit, for gross procee...

The Canadian Securities Exchange today announced its market statistics for the month of August 2021, which was highlighted by large financings in the cannabis and mining sectors.August 2021 Operating... | September 15, 2021

The Horizons Psychedelic Stock Index ETF is now listed on Toronto’s NEO exchange under the symbol &lsquo...

/PRNewswire/ -- KCSA Strategic Communications, an integrated strategic communications firm specializing in public relations, investor relations and social...

Compass Launches Center Of Excellence Compass Pathways (NASDAQ:CMPS) o...

Psychedelics biotech company Entheon Biomedical Corp. (CSE:ENBI) has purchased b...

NEW YORK, Jan. 11, 2021 /PRNewswire/ --?KCSA Strategic Communications, an integrated strategic communications firm specializing in public relations, investor relations and social media, today... | January 11, 2021

/PRNewswire/ -- KCSA Strategic Communications, an integrated strategic communications firm specializing in public relations, investor relations and social...